← Return to Bispecific antibodies For Multiple Myeloma

Discussion
lgeorge avatar

Bispecific antibodies For Multiple Myeloma

Blood Cancers & Disorders | Last Active: Aug 31 10:07am | Replies (7)
Comment receiving replies
Profile picture for Colleen Young, Connect Director @colleenyoung

@scottp777, it sounds like the trial drug helped you. Should treatment be necessary in the future are you eligible for one of the other approved drugs?

Jump to this post

Replies to "@scottp777, it sounds like the trial drug helped you. Should treatment be necessary in the future..."
scottp777 | @scottp777 | Apr 6 1:58pm

I am still eligible for Cart-T, and a host of other treatments. AMG701 was a bi-specific to BCMA/CD3, and since I responded well to it, there is an expectation that CART-T would work well also, should I need it in the future.

VIEW AND REPLY